More Compelling Evidence to Support Hip Resurfacing Arthroplasty

More compelling evidence to support hip resurfacing arthroplasty. Published September 9, 2020, the paper discusses a study delivered by twenty seven hip resurfacing professionals from thirteen countries who collaborated to review a cohort of 11,382 hip resurfacing arthroplasties.

The focus was on a varied group of patients both male and female, ⩽50 years of age and aimed to analyse arthroplasty outcomes with a mean follow-up of 7.6 years. In total, 18 different metal-on-metal (MoM) hip resurfacing designs were included in the study.

​In men, implant survivorship was excellent: 99% at 10 years and 92.5% at 21 years.

In females, implant survivorship was 90% at 10 years and 81.3% at 22 years.

Implant survivorship of 11,063 cases was 95% at 10 years and 90% at 22 years. 

​The authors note Higher demands for activity and functionality in younger patients make HRA a potential alternative to Total Hip Arthroplasty (THA).

Follow this link to read more: Hip resurfacing arthroplasty in young patients: international high-volume centres’ report on the outcome of 11,382 metal-on-metal hip resurfacing arthroplasties in patients ⩽50 years at surgery